Nov 7 (Reuters) - Nektar Therapeutics:
* Nektar Therapeutics reports financial results for the third quarter of 2017
* Q3 earnings per share $0.39
* Q3 revenue $152.9 million versus $36.3 million
* Q3 revenue view $114.6 million -- Thomson Reuters I/B/E/S
* Q3 earnings per share view $0.17 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.